PMR Publications >> Pharma >> Distribution on the pharmaceutical market in Poland 2010



You have no products in your basket!

Distribution on the pharmaceutical market in Poland 2010

Development forecasts for 2010-2012


 Polish version also available!


Related products:

Pharma Poland Online
Pharma Poland News
Central Europe Pharma News
Imaging diagnostics market in Poland 2010
Dietary supplements market in Romania 2010
Price
(starting from)
  €1 800
add to basket
buy now
Date: 2010-02-05
Language: English or Polish
No. pages: 195
Delivery: PDF file
Distribution on the pharmaceutical market in Poland 2010

  description    |    table of contents    |    table of graphs and tables    |    leaflet    |    free article    |    request more info 

Description:


The aim of the report is to provide the complex analysis of the distribution on the pharmaceutical market in Poland. It focuses on the analysis of the main market segments i.e.:

  • pharmacy distribution
  • non-pharmacy distribution
  • hospital distribution

providing segments’ characteristic and profiles of leading players in each segment. Direct distribution and exclusive distribution are also analysed, as well as parallel imports and exports.

Moreover, the report presents the results of a unique survey carried out by PMR among leading pharmaceutical companies on the Polish pharmaceutical market.

Distribution on the pharmaceutical market in Poland 2010, Development forecasts for 2010-2012 provides feedback from industry insiders directly from a new PMR market survey, as well as solid forecasting that focuses on how pharmaceutical product makes its way into the hands of Polish consumers during the next two years.

Table of contents:


  1. Report methodology

  2. Executive summary

  3. Overview of distribution on the pharmaceutical market in Poland in the years 2005-2012

    • Key events and trends in the years 2008-2009
    • Expected events and trends in the years 2010-2012
    • Value of various distribution channels in the years 2005-2012
      • Share of various distribution channels in market value
      • The pharmacy distribution market
      • The hospital distribution market
  4. Pharmacy distribution

    • Wholesale distribution
      • Numbers and types of wholesalers
      • Concentration of wholesalers on the pharmacy market
      • The largest players on the pharmacy market
      • Full-line distribution
        • Profile of the model
        • Profiles of selected leading players
      • Short-line distribution
        • Profile of the model
        • Profiles of selected leading players
    • Pharmacy distribution
      • Number of pharmacies
      • Financial condition of pharmacies
      • Customer numbers in pharmacies
      • Pharmacy cooperation with wholesalers
      • Pharmacy chains
        • Pharmacy chains with connections to wholesalers
          • Profiles of selected leading players
        • Independent pharmacy chains
          • Chains of over 20 pharmacies
            • Profiles of selected leading players
          • Pharmacy chains numbering 10-20 outlets
            • Profiles of selected leading players
          • Pharmacy chains of fewer than 10 outlets
            • Profiles of selected leading players
      • Pharmacy franchise chains
      • Pharmacy buying groups
      • Pharmacy points
      • Internet pharmacies
        • Profile of the segment
        • The internet pharmacy as a place to buy drugs
        • Number of internet pharmacies
        • Leading internet pharmacies
          • Profiles of selected leading players
  5. Non-pharmacy distribution

    • Profile of the segment
    • Advertising of OTC drugs in retail chains’ magazines
    • Entities distributing drugs via the non-pharmacy channel
    • Wholesale distribution
      • Profiles of selected leading players specialising in non-pharmacy distribution
    • Retail distribution
      • General stores
        • Hypermarkets
        • Supermarkets
        • Discount stores
        • Small grocery stores
        • Convenience stores
        • Shops at petrol stations
      • Kiosks
      • Cosmetics/drugstores
      • Herbal/medical shops
  6. Hospital distribution

    • Profile of the segment
    • The financial condition of hospitals in Poland
    • Biggest players on the hospital market
      • Profiles of selected leading players
  7. Direct, DTP and exclusive distribution

    • Key features of the models
    • The legal environment
    • Examples of manufacturers using direct distributin or DTP on the Polish market
  8. Parallel trade

    • Parallel import
      • Legal environment
      • Number of parallel import permits
      • Market size
      • Reimbursement of parallel import drugs
      • Biggest players on the parallel imports market
        • Profiles of leading players
    • Parallel export
  9. Results of the survey conducted among the largest pharmaceutical companies in Poland

    • Development of distribution channels on the pharmaceutical market
      • Internet sales
      • Sales in general stores
      • Direct distribution
      • Exclusive distribution
    • Other services rendered by distributors
    • Expected impact of legal changes on the pharmaceutical market
  10. Annex 1

    • List of drugs approved for sale in general stores
  11. List of graphs

  12. List of tables

  13. About PMR

  14. Contact PMR

List of graphs and Tables:


List of graphs

  1. Place where Poles buy medical supplies, 2008
  2. Revenues and net result (PLN m) of CF Cefarm in Poland, 2007-2008
  3. Estimated shares of various distribution channels in the pharmaceutical market in Poland, 2009
  4. Value (PLN bn) and dynamics of the pharmacy market in Poland, 2005-2012
  5. Value (PLN bn) and dynamics of the hospital drugs market in Poland, 2005-2012
  6. Location of pharmaceutical wholesalers’ warehouses in Poland, by voivodship, November 2009
  7. Number of pharmaceutical wholesalers’ warehouses with licences for trade in specific ranges of medical products, by type of products sold, November 2009
  8. Market shares of the 10 largest wholesalers on the pharmacy market in Poland, 1994-Q2 2009
  9. Shares of wholesale groups in distribution to pharmacies in Poland, Q2 2009
  10. Market shares of largest players on the pharmaceutical wholesale market in Poland, by sales to pharmacies, Q3 2009
  11. Full-line distribution model in Poland, 2010
  12. The Torfarm group’s wholesale logistics structure in Poland, 2009
  13. Torfarm group sales revenues (PLN m) and their dynamics in Poland, 2003-Q3 2009
  14. Torfarm group net profits (PLN m) and their dynamics in Poland, 2003-Q3 2009
  15. Torfarm group sales structure, breakdown by dependent companies, Q1-3 2009
  16. Structure of the PGF capital group, 2009
  17. The PGF group’s wholesale logistics structure in Poland, 2009
  18. PGF group sales revenues (PLN m) and their dynamics, 2001-Q3 2009
  19. PGF group net profits (PLN m) and their dynamics, 2001-Q3 2009
  20. Sales structure of the PGF group, Q1-Q3 2009
  21. The Farmacol group’s wholesale logistics structure in Poland, 2009
  22. Farmacol sales revenues (PLN m) and their dynamics in Poland, 2004-Q3 2009
  23. Farmacol group net profits (PLN m) and their dynamics in Poland, 2004-Q3 2009
  24. Revenues and net profits (PLN m) of Cefarm Bialystok in Poland, 2004-2008
  25. Mediq group structure, 2009
  26. The ACP Pharma wholesale distribution logistics structure in Poland, 2009
  27. ACP Pharma wholesale revenues in Poland (€ m) and their dynamics, 2005-Q3 2009
  28. ACP Pharma sales structure in Poland, Q3 2009
  29. The Phoenix Pharma wholesale distribution logistics structure in Poland, 2009
  30. Phoenix Pharma sales revenues (PLN m) in Poland and their dynamics, 2004/2005-2008/2009
  31. Net result (PLN m) of Phoenix Pharma in Poland, 2004/2005-2008/2009
  32. OPDF shareholder structure in Poland, 2009
  33. The Hurtap wholesale distribution logistics structure in Poland, 2009
  34. Hurtap sales revenues (PLN m) and their dynamics in Poland, 2003-2008
  35. Hurtap’s net profits (PLN m) and their dynamics in Poland, 2003-2008
  36. Multi Pharme revenues and net profits (PLN m) in Poland, 2004-2008
  37. Intra sales revenues (PLN m) and their dynamics in Poland, 2003-2008
  38. Intra’s net profits (PLN m) and their dynamics in Poland, 2003-2008
  39. Medicare sales revenues (PLN m) and their dynamics in Poland, 2003-2007
  40. Medicare net profits (PLN m) and their dynamics in Poland, 2003-2007
  41. Lubfarm revenues (PLN m) in Poland and their dynamics, 2003-2007
  42. Lubfarm net profits (PLN m) in Poland and their dynamics, 2003-2007
  43. Preska sales revenues (PLN m) in Poland and their dynamics, 2003-2007
  44. Preska net result (PLN ‘000) in Poland and their dynamics, 2003-2007
  45. Salus International sales revenues (PLN m) in Poland and their dynamics, 2002-2008
  46. Salus International net profits (PLN m) in Poland and their dynamics, 2002-2008
  47. Short-line distribution model in Poland, 2010
  48. Pretium Farm revenues (PLN m) in Poland and their dynamics, 2006-Q3 2009
  49. Estimated sales structure of Pretium Farm in Poland, 2009
  50. Number of pharmacy outlets in Poland, by type, December 2009
  51. Number of pharmacy outlets in Poland, by voivodship, December 2009
  52. Number of residents per pharmacy outlet in Poland, by voivodship, December 2009
  53. Average monthly revenues of pharmacies (PLN ‘000) and their dynamics in Poland, January-November 2009
  54. Average numbers of customers to pharmacies (‘000) in Poland, January-November 2009
  55. Number of pharmacies belonging to pharmacy chains in Poland, Q2 2009
  56. Largest pharmacy chains owned by pharmaceutical wholesalers in Poland, Q3 2009
  57. Pharmacies belonging to Farmacol in Poland, by name, December 2009
  58. Pharmacies belonging to ACP Pharma in Poland, by name, Q3 2009
  59. ACP Pharma retail sales revenues in Poland (€ m) and their dynamics, 2005-Q3 2009
  60. Selected largest independent pharmacy chains in Poland (no. of outlets), with over 20 outlets, December 2009
  61. Revenues and net result of  xxx in Poland (PLN m), 2004-2008
  62. Revenues and net result of xxx in Poland (PLN m), 2003-2007
  63. Pharmacies in the xxxchain (no. of outlets according to proprietor) in Poland, December 2009
  64. xxx sales revenues in Poland (PLN m), 2006-2007
  65. Revenues and net result of xxx in Poland (PLN m), 2004-2008
  66. Selected largest independent pharmacy chains in Poland (no. of outlets), 10-20 outlets, December 2009
  67. Revenues and net profit of xxx in Poland (PLN m), 2004-2008
  68. Revenues and net profit of xxx in Poland (PLN m), 2004-2008
  69. Revenues and net profit of xxx in Poland (PLN m), 2004-2007
  70. Pharmacies in the xxx chain (no. of outlets by proprietor) in Poland, December 2009
  71. Revenues and net profits of xxx in Poland (PLN m), 2003-2007
  72. Revenues and net profit of xxx in Poland (PLN m), 2004-2008
  73. Selected largest independent pharmacy chains in Poland (no. of outlets), 7-9 outlets, December 2009
  74. Selected largest independent pharmacy chains in Poland (no. of outlets), 5-6 outlets, December 2009
  75. Pharmacies belonging to the xxx in Poland, December 2009
  76. Revenues and net profit of xxx in Poland (PLN m), 2004-2008
  77. Revenues and net profit of xxx in Poland (PLN m), 2005-2008
  78. Revenues and net profit of xxx in Poland (PLN m), 2003-2007
  79. Pharmacies owned by xxx in Poland, December 2009
  80. Revenues of xxx and xxx in Poland (PLN m), 2006-2008
  81. Most popular internet pharmacies in Poland, by numbers of real users, October 2009
  82. Comparison of user numbers (real users) of the most popular internet pharmacies in Poland, Q1 2008, December 2008 and October 2009
  83. Most popular internet pharmacies in Poland by numbers of hits, October 2009
  84. Most popular internet pharmacies in Poland by numbers of hit per user, October 2009
  85. Most popular internet pharmacies in Poland by average time spent per user (h: min: s), October 2009
  86. Most popular internet pharmacies in Poland by penetration among internet users, October 2009
  87. Sales revenues and net financial result of DomZdrowia.pl in Poland (PLN ‘000), 2007-Q3 2009
  88. Number of promotions of OTC drugs in magazines of drugstore and retail chains in Poland, 1st-37th weeks of 2007 and 2008
  89. Non-pharmacy distribution model in Poland, 2010
  90. xxx pharmaceutical distribution structure in Poland, December 2009
  91. xxx pharmaceutical distribution structure in Poland, December 2009
  92. xxx pharmaceutical distribution structure in Poland, December 2009
  93. xxx pharmaceutical distribution structure in Poland, December 2009
  94. xxx pharmaceutical distribution structure in Poland, December 2009
  95. Shares of various retail formats in the grocery market in Poland, by sales, 2009
  96. Share of various store formats in non-pharmacy sales of OTC drugs, by value, December 2008-November 2009
  97. Sales structure of OTC products in hypermarkets in Poland, by value, December 2008-November 2009
  98. Sales structure of OTC products in supermarkets in Poland, by value, December 2008-November 2009
  99. Sales structure of OTC products in small-format stores (area of 101-300 m2) in Poland, by value, December 2008-November 2009
  100. Sales structure of OTC products in small-format stores (area of 40-100 m2) in Poland, by value, December 2008-November 2009
  101. Sales structure of OTC products in small-format stores (area of under 40 m2) in Poland, by value, December 2008-November 2009
  102. No. of petrol stations owned by the major fuel concerns in Poland, Q3 2009
  103. Sales structure of OTC products in shops at petrol stations in Poland, by value, December 2008-November 2009
  104. Estimated number of kiosks in the chains of the largest press distributors in Poland, Q3 2009
  105. Sales structure of OTC products in kiosks in Poland, by value, December 2008-November 2009
  106. Selected largest cosmetics/drugstore chains in Poland (no. of stores), December 2009
  107. Drug distribution model on the hospital market in Poland, 2010
  108. Enforceable debt of SP ZOZ in Poland (PLN bn), Q1 2005-Q3 2009
  109. Total debt of SP ZOZ in Poland (PLN bn), Q1 2005-Q3 2009
  110. Wholesale groups’ shares in distribution to hospitals in Poland, Q2 2009
  111. Sales to hospitals compared to total sales revenues of PGF (PLN m) in Poland, 2007-Q3 2009
  112. Revenues and net profits of xxx in Poland (PLN m), 2001-2008
  113. Value of xxx sales of selected drugs offered to the hospital segment (PLN m) in Poland, 2005-2006
  114. Revenues and net profit of xxx in Poland (PLN m), 1999-2008
  115. Revenues and net profit of xxx in Poland (PLN m), 2006-2008
  116. DTP (direct-to-pharmacy) distribution model in Poland, 2010
  117. Direct distribution model in Poland, 2010
  118. Wholesale distribution channels of dermocosmetics in Poland, 2008
  119. Distribution models on the dermocosmetics market in Poland, October 2008
  120. No. of applications submitted and no. of parallel import permits issued in Poland, 2004-August 2009
  121. Countries of origin of drugs imported to Poland as parallel imports, by no. of permits, 2009
  122. Sales value of parallel import drugs in Poland (PLN m), Q1 2006-Q4 2009
  123. No. of packets of parallel import drugs sold in Poland (million), Q1 2008-Q3 2009
  124. The Polish market of parallel importers, by numbers of permits, 2009
  125. Revenues and net profit (PLN m) of xxx in Poland, 2005-H1 2009
  126. Revenues and net profit (PLN m) of xxx in Poland, 2008-May 2009
  127. Revenues and net profit (PLN m) of xxx in Poland, 2004-2008
  128. Revenues and net profit (PLN m) of xxx in Poland, 2007-2008
  129. Average manufacturer price (MSRP) per comparable drug unit in Poland and other European countries, 2008
  130. Evaluation of the sales development dynamic in various distribution channels compared to the overall market over the next 12 months in Poland, 2009
  131. Best-selling product categories in the internet channel over the next two years in Poland, 2009
  132. Product categories that will sell best in general stores over the next two years in Poland, 2009
  133. Penetration and type of direct distribution used on the pharmaceutical market in Poland, 2009
  134. Are you considering implementing direct distribution?, 2009
  135. Comparison of revenues of firms not using and not planning to use direct distribution with whole-sample average, 2009
  136. Do you currently use an exclusive distribution system?, 2009
  137. Are you considering introducing exclusive distribution?, 2009
  138. Reasons for not using the exclusive distribution model in Poland, 2009
  139. Additional services offered by wholesalers and logistics operators most sought after by manufacturers in Poland, 2009
  140. Evaluation of the impact of the planned introduction of fixed margins and prices of reimbursed drugs on various market players in Poland, 2009
  141. Evaluation of the impact of the planned tightening up of anticoncentration rule on various market players in Poland, 2009

List of tables

  1. Acquisitions by Torfarm in the wholesale segment in Poland, 2007-2009
  2. Takeovers by PGF in the wholesale segment, 2007-2009
  3. Takeovers by Farmacol in the wholesale segment in Poland, 2008-2009
  4. Selected pharmacy takeovers by PGF in Poland, 2007-2008
  5. Revenues and net financial result of selected pharmacies and pharmacy chains owned by xxx in Poland, 2007/2008
  6. Revenues and net financial result of selected pharmacies and pharmacy chains owned by xxx in Poland, 2007/2008
  7. Revenues and net financial result of selected pharmacies and pharmacy chains owned by xxx in Poland, 2007/2008
  8. Revenues and net financial result of selected pharmacies and pharmacy chains owned by xxx in Poland, 2007/2008
  9. Revenues and net financial result of selected pharmacies and pharmacy chains belonging to xxx in Poland, 2007/2008
  10. Revenues and net financial result of selected pharmacies and pharmacy chains belonging to xxx in Poland, 2007
  11. Revenues and net financial result of selected pharmacies and pharmacy chains belonging to xxx in Poland, 2007
  12. Internet pharmacies operating in Poland, December 2009
  13. Comparison of delivery terms of selected internet pharmacies in Poland, December 2009
  14. Hypermarket chains in Poland by value of sales and number of outlets, 2008 and 2009
  15. Largest supermarket chains in Poland by value of sales and no. of stores, 2008 and 2009
  16. Discount chains in Poland by value of sales and no. of stores, 2008 and 2009
  17. Largest chains of small grocery stores in Poland by value of sales and number of stores, 2008 and 2009
  18. Largest convenience store chains in Poland, by value of sales and no. of stores, 2008 and 2009
  19. Herbal/medical shops in Poland by voivodship, 2008
  20. Comparison of direct distribution and traditional distribution models on the pharmaceutical market, 2009
  21. Comparison of the wording of the Pharmaceutical Law and Directive in the area of fulfilling supply obligations
  22. Parallel import drugs eligible for reimbursement in Poland, 2009
  23. Manufacturers and countries of origin of drugs imported by xxx as parallel imports to Poland, 2009
  24. Manufacturers and countries of origin of drugs imported by xxx as parallel imports to Poland, 2009
  25. Manufacturers and countries of origin of drugs imported by xxx as parallel imports to Poland, 2009
  26. Manufacturers and countries of origin of drugs imported by xxx as parallel imports to Poland, 2009
  27. Extent to which direct distribution is used in Poland, 2009
  28. List of drugs approved for sales in general stores in Poland, October 2009

Request for more information :


In order to receive more detailed information of:

Distribution on the pharmaceutical market in Poland 2010 Development forecasts for 2010-2012

please fill in the form below.

None of this information will be disclosed to third parties.
To be assured that we take your privacy seriously, please read our Privacy Policy.

Please fill out all the fields correctly. Information will only be provided if forms are adequately completed.


(optional):
FREE online demonstration of the product (15 minutes interactive teleconference)
PMR reserves the right to refuse and / or withdraw this service without justification or prior notification

Email:
In order to make sure you receive our information, please add our email address: info@pmrcorporate.com to the list of safe sources in your company. Please contact your IT department for details. Thank you.

Choose sector of interest: (You must specify at least one sector)

construction: retail: pharma: it & telecom: general economy:

Additional:
(specify)

Please read our Privacy Policy.

Download white paper:




  description    |    table of contents    |    table of graphs and tables    |    leaflet    |    free article    |    request more info 

Copyright © 2010 PMR
All rights reserved.

 
PMR PMR Consulting PMR Research Polish Business Market China Business Market Careers at PMR
Retail Poland Retail Russia Central Europe Retail Pharma market Poland Pharma market Central Europe
Construction Russia Construction Poland Construction Ukraine Construction market CEE Rynek Budowlany
Telecoms Poland Telecoms Russia CEE Telecoms Business market Central Europe Analiza Rynku Links